Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2012 08:20 ET | Source: Amarantus BioSciences

Amarantus BioSciences Announces the Release of Research Report by TomorrowsBlueChips.com

SUNNYVALE, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences Inc. (OTCBB:AMBS), a California-based biotechnology company focused on the development of a therapeutic protein known as...
March 16, 2012 10:13 ET | Source: Amarantus BioSciences

Amarantus BioSciences' CEO Gerald Commissiong to Appear on the Big Biz Radio Show

SUNNYVALE, Calif., March 16, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today...
January 06, 2012 09:10 ET | Source: Amarantus BioSciences

Amarantus Biosciences Releases New Video Interview With President and CEO Gerald Commissiong

SUNNYVALE, Calif., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences Inc. (OTCBB:AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the...
November 29, 2011 06:08 ET | Source: Amarantus BioSciences

New Webcast Interview With President and CEO Gerald Commissiong Now Available at TheGreenBaron.com

SUNNYVALE, Calif., Nov. 29, 2011 (GLOBE NEWSWIRE) -- Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein,...
November 14, 2011 11:05 ET | Source: Amarantus BioSciences

Amarantus Biosciences, a Promising Biotech Company in Development

MIAMI, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Founded in California in 2008, Amarantus Biosciences, Inc. (OTCBB:AMBS) is now poised to take the biotech world by storm with their proprietary new technology....